ACTA NEUROPHARMACOLOGICA››2021,Vol. 11››Issue (1): 30-37.DOI:10.3969/j.issn.2095-1396.2021.01.005

Previous ArticlesNext Articles

Application of Curcumin and Its Nanoparticles in the Treatment of Central Nervous System Diseases

XU Jie,JIANGYan,ZHANG Xinxin,ZHAO Liyan,ZHANG Wanming#br#

  1. College of Pharmacy,Hebei North University,Hebei Key Laboratory of Neuropharmacology,Zhangjiakou,075000,China
  • Online:2021-02-26Published:2021-02-26
  • Contact:张万明,教授,硕士生导师;研究方向:药物分析、药理学研究;Email:429269523@163.com
  • About author:许洁,在读硕士研究生;研究方向:药物分析、药理学研究;Email:540963048@qq.com
  • Supported by:
    河北省教育厅高校基本科研业务费(No.JYT2020002),河北省卫生健康委科研基金项目(No.20180812)

Abstract:

Curcumin is a kind of hydrophobic polyphenol extracted from the rhizome of Curcuma. It has many pharmacological effects, such as anti-cancer, anti-inflammatory and anti-oxidation. It can improve the symptoms of cancer, diabetes and brain injury. With the development of research, it has been found that it has good anti-inflammatory and neuroprotective effects. Curcumin has been proved to have good potential in the treatment of nervous system diseases. However, poor solubility, low stability, rapid clearance rate in vivo and poor permeability of blood-brain barrier (BBB) limit its clinical application. In recent years, nanoparticles based drug delivery systems have effectively improved the water solubility and bioavailability of Curcumin. In this review, effects and possible mechanisms of Curcumin and its nanoparticles have been elucidated in a variety of central nervous system (CNS) related diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis and glioblastoma, etc.

Key words:curcumin,neuroprotective,nerve center,nanodosage,bioavailability

CLC Number:

Baidu
map